Larotrectinib for treating NTRK fusion-positive advanced solid tumours (MA review of TA630) [ID6292]

Draft guidance

Draft guidance (downloadable version) (PDF 371 KB)

Draft guidance (online commenting)

Committee papers (PDF 7.25 MB)

Public committee slides (PDF 771 KB)

Final scope (PDF 175 KB)

Final stakeholder list (PDF 166 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 371 KB)

Draft scope post referral (PDF 104 KB)